2023
Potard V., Lakrout P., Marshall E., Cadranel J., Jacomet C., Katlama C., Makinson A., Lambotte O., Lavolé A., Palich R.1,, Ronot S., Spano JP., Costagliola D., Grabar S., for the ANRS CO4 FHDH study group. Notification rates of cancers in the ANRS CO4 FHDH cohort
2022
Choufany M., Marshall E., Maria A., Mayeux A., Spire B., Grabar S., Costagliola D. Éligibilité à l’assurance emprunteur selon la grille de référence AERAS de 2017, 2021 et 2022 des PVVIH suivies dans la base ANRS CO4 FHDH
Marty L, Diawara Y, Rachas A, Grabar S, Costagliola D, Supervie V. Projection of age and time since ART initiation of persons living with HIV in 2030 : estimates for France
Choufany M., Weiss L., Makinson A. , Roul H. , Livrozet J-M. , Pourcher V., Melica G. , Rioux C. , Viard J-P., Marshall E. , Grabar S. , Costagliola D. Decline In CD4 Counts And Risk Of Severe Morbidity In PLHIV After Initiating CART
2021
Requena M, Grabar S, Costagliola D and Lacombe K. Higher all-cause mortality in individuals living with HIV cured of HCV by direct-acting antivirals compared to HIV mono-infection despite controlled HIV: Results from the ANRS-CO4 FHDH cohort
